EGFR Mutations, Gene Amplification, and Protein Expression and KRAS Mutations in Primary and Metastatic Tumors of Nonsmall Cell Lung Cancers and Their Clinical Implications: A Meta-Analysis

By Han Chengbo   Ma Jietao   Zhao Jianzhu   Zhou Yang   Jing Wei   Zou Huawei  

Cancer Investigation, Vol. 29, Iss. 9, 2011-10 ,pp. : 626-634

Informa Healthcare

Access to resources Recommend Favorite

Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in metastatic colorectal cancer: A systematic review and meta-analysis

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 959-967

Science Publishers

Access to resources Recommend Favorite

KRAS Mutation Analysis Prior to EGFR-Directed Therapy for Metastatic Colorectal Cancer: A Review and Cost Analysis

By  

Current Cancer Therapy Reviews, Vol. 6, Iss. 4, 2010-11 ,pp. : 256-261

Bentham Science Publishers

Access to resources Recommend Favorite

Association between codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis

By Chen Jian   Ye Yun   Sun Haozhen   Shi Genming  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 265-272

Springer Publishing Company

Access to resources Recommend Favorite

Geographic and Temporal Trends in the Management of Occult Primary Breast Cancer: A Systematic Review and Meta-Analysis

By Fayanju Oluwadamilola   Stoll Carolyn   Fowler Susan   Colditz Graham   Jeffe Donna   Margenthaler Julie  

Annals of Surgical Oncology, Vol. 20, Iss. 10, 2013-10 ,pp. : 3308-3316

Springer Publishing Company

Access to resources Recommend Favorite